Recent Updates
Recently added Catalysts
ECOR Positive Sentiment Score: 75/100

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

Thursday, November 14, 2024 1 min read
Key Takeaway: electroCore, Inc. announced its participation in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, scheduled for November 21, 2024, in New York City. CFO Joshua Lev will host one-on-one meetings with investors during the event. The forum is an opportunity for the company to enhance its visibility and discuss its non-invasive vagus nerve stimulation technology, which aims to improve health and wellbeing. Interested investors are encouraged to schedule meetings through their CG representative for further engagement.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a significant industry event showcases company visibility.
  • Opportunity for one-on-one meetings could attract investor interest.
  • Focus on innovative bioelectronic medicine promotes growth potential.

Full Press Release Details

ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum taking place in New York City on November 21, 2024.
Joshua Lev, Chief Financial Officer, will host one-on-one meetings throughout the day.
To schedule a one-on-one meeting with Mr. Lev, investors are encouraged to reach out to their CG representative. For more information regarding the event please visit https://www.meetmax.com/sched/event_110807/conference_home.html.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
ECOR Investor Relations
investors@electrocore.com

Tags

Frequently Asked Questions

When will electroCore participate in the Canaccord Genuity Forum?

electroCore will participate in the Forum on November 21, 2024.

Who is hosting one-on-one meetings at the event?

Joshua Lev, the Chief Financial Officer, will host the one-on-one meetings.

How can investors schedule meetings with Mr. Lev?

Investors can schedule meetings by contacting their Canaccord Genuity representative.

What is the focus of electroCore, Inc.?

electroCore focuses on bioelectronic medicine, particularly non-invasive vagus nerve stimulation.

Where can I find more information about electroCore?

For more information, visit electroCore's website at www.electrocore.com.

Tags: ECOR Viatris Investor Conferences Healthcare bioelectronic medicine vagus nerve stimulation investor meetings Canaccord Genuity
Last updated: Nov 14, 2024